Insulin treatment is essential for people with T1DM, not only to limit hyperglycaemia but also to avoid other severe metabolic disturbances such as hypertriglyceridemia and diabetic ketoacidosis (DKA) [5]. This evidence concerns the gene INS and hypertriglyceridemia.